FANCM and FAAP24 Function in ATR-Mediated Checkpoint Signaling Independently of the Fanconi Anemia Core Complex

Molecular Cell

Volumn 32, Issue 3, 2008, Pages 313-324

  Collis, Spencer J ^a   Ciccia, Alberto ^a,b   Deans, Andrew J ^a   Hořejší, Zuzana ^a   Martin, Julie S ^a   Maslen, Sarah L ^a   Skehel, J Mark ^a   Elledge, Stephen J ^b   West, Stephen C ^a   Boulton, Simon J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

DNA; SIGNALING

Indexed keywords

ATR PROTEIN; CHECKPOINT KINASE 1; FAAP24 PROTEIN; FANCM PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; DNA DAMAGE; DOWN REGULATION; FANCONI ANEMIA; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

CELL LINE; DNA DAMAGE; DNA HELICASES; DNA REPAIR; DNA REPLICATION; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; FANCONI ANEMIA; GENOME; HELA CELLS; HUMANS; KIDNEY; MITOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; S PHASE; SIGNAL TRANSDUCTION;

EID: 55049111236     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2008.10.014     Document Type: Article

References (47)

1. Alderton G.K., Joenje H., Varon R., Borglum A.D., Jeggo P.A., and O'Driscoll M. Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Hum. Mol. Genet. 13 (2004) 3127-3138
2. Andreassen P.R., D'Andrea A.D., and Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18 (2004) 1958-1963
3. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5 (2004) 792-804
4. Brown E.J., and Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 17 (2003) 615-628
5. Butler M.G., Hall B.D., Maclean R.N., and Lozzio C.B. Do some patients with Seckel syndrome have hematological problems and/or chromosome breakage?. Am. J. Med. Genet. 27 (1987) 645-649
6. Ciccia A., Ling C., Coulthard R., Yan Z., Xue Y., Meetei A.R., Laghmani el H., Joenje H., McDonald N., de Winter J.P., et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25 (2007) 331-343
7. Collis S.J., Barber L.J., Clark A.J., Martin J.S., Ward J.D., and Boulton S.J. HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. Nat. Cell Biol. 9 (2007) 391-401
8. Cuadrado M., Martinez-Pastor B., Murga M., Toledo L.I., Gutierrez-Martinez P., Lopez E., and Fernandez-Capetillo O. ATM regulates ATR chromatin loading in response to DNA double-strand breaks. J. Exp. Med. 203 (2006) 297-303
9. Dickins R.A., Hemann M.T., Zilfou J.T., Simpson D.R., Ibarra I., Hannon G.J., and Lowe S.W. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37 (2005) 1289-1295
10. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
11. Gari K., Decaillet C., Stasiak A.Z., Stasiak A., and Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell 29 (2008) 141-148
12. Griffith E., Walker S., Martin C.A., Vagnarelli P., Stiff T., Vernay B., Al Sanna N., Saggar A., Hamel B., Earnshaw W.C., et al. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat. Genet. 40 (2008) 232-236
13. Hinz J.M., Nham P.B., Salazar E.P., and Thompson L.H. The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair (Amst.) 5 (2006) 875-884
14. Hinz J.M., Nham P.B., Urbin S.S., Jones I.M., and Thompson L.H. Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res. 35 (2007) 3733-3740
15. Ho G.P., Margossian S., Taniguchi T., and D'Andrea A.D. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26 (2006) 7005-7015
16. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
17. Hurley P.J., Wilsker D., and Bunz F. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. Oncogene 26 (2006) 2535-2542 10.1038/sj.onc.1210049 Published online October 16, 2006
18. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., and Jackson S.P. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8 (2006) 37-45
19. Kim J.M., Kee Y., Gurtan A., and D'Andrea A.D. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 111 (2008) 5215-5222 10.1182/blood-2007-09-113092 Published online January 3, 2008
20. Levitus M., Joenje H., and de Winter J.P. The Fanconi anemia pathway of genomic maintenance. Cell. Oncol. 28 (2006) 3-29
21. Lukas J., Lukas C., and Bartek J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst.) 3 (2004) 997-1007
22. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
23. Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 (2005) 958-963
24. Mosedale G., Niedzwiedz W., Alpi A., Perrina F., Pereira-Leal J.B., Johnson M., Langevin F., Pace P., and Patel K.J. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12 (2005) 763-771
25. Myers J.S., and Cortez D. Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J. Biol. Chem. 281 (2006) 9346-9350
26. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., and Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15 (2004) 607-620
27. Nojima K., Hochegger H., Saberi A., Fukushima T., Kikuchi K., Yoshimura M., Orelli B.J., Bishop D.K., Hirano S., Ohzeki M., et al. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65 (2005) 11704-11711
28. O'Driscoll M., and Jeggo P.A. Clinical impact of ATR checkpoint signalling failure in humans. Cell Cycle 2 (2003) 194-195
29. O'Driscoll M., Dobyns W.B., van Hagen J.M., and Jeggo P.A. Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling. Am. J. Hum. Genet. 81 (2007) 77-86
30. Papadopoulo D., Guillouf C., Mohrenweiser H., and Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. USA 87 (1990) 8383-8387
31. Petermann E., and Caldecott K.W. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 5 (2006) 2203-2209
32. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M., et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 39 (2007) 162-164
33. Sengupta S., Robles A.I., Linke S.P., Sinogeeva N.I., Zhang R., Pedeux R., Ward I.M., Celeste A., Nussenzweig A., Chen J., et al. Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J. Cell Biol. 166 (2004) 801-813
34. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald III E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., and Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129 (2007) 289-301
35. Stiff T., Reis C., Alderton G.K., Woodbine L., O'Driscoll M., and Jeggo P.A. Nbs1 is required for ATR-dependent phosphorylation events. EMBO J. 24 (2005) 199-208
36. Stiff T., Walker S.A., Cerosaletti K., Goodarzi A.A., Petermann E., Concannon P., O'Driscoll M., and Jeggo P.A. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25 (2006) 5775-5782
37. Syljuasen R.G., Sorensen C.S., Hansen L.T., Fugger K., Lundin C., Johansson F., Helleday T., Sehested M., Lukas J., and Bartek J. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol. Cell. Biol. 25 (2005) 3553-3562
38. Takai H., Wang R.C., Takai K.K., Yang H., and de Lange T. Tel2 Regulates the stability of PI3K-related protein kinases. Cell 131 (2007) 1248-1259
39. Takeda D.Y., and Dutta A. DNA replication and progression through S phase. Oncogene 24 (2005) 2827-2843
40. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
41. Tripathi V., Kaur S., and Sengupta S. Phosphorylation-dependent interactions of BLM and 53BP1 are required for their anti-recombinogenic roles during homologous recombination. Carcinogenesis 29 (2008) 52-61
42. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8 (2007) 735-748
43. Wang X., Kennedy R.D., Ray K., Stuckert P., Ellenberger T., and D'Andrea A.D. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 27 (2007) 3098-3108
44. Wilson J.B., Johnson M.A., Stuckert A.P., Trueman K.L., May S., Bryant P.E., Meyn R.E., D'Andrea A.D., and Jones N.J. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. Carcinogenesis 22 (2001) 1939-1946
45. Xia B., Dorsman J.C., Ameziane N., de Vries Y., Rooimans M.A., Sheng Q., Pals G., Errami A., Gluckman E., Llera J., et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39 (2007) 159-161
46. Xue Y., Li Y., Guo R., Ling C., and Wang W. FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet. 17 (2008) 1641-1652 10.1093/hmg/ddn054 Published online February 19, 2008
47. Zou L., and Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300 (2003) 1542-1548